Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism.
about
Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinomaEndogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.Peptide nucleic acids: versatile tools for gene therapy strategies.Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.Antisense properties of duplex- and triplex-forming PNAs.Use of fully modified 2'-O-methyl antisense oligos for loss-of-function studies in vertebrate embryos.Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.DNA and RNA derivatives to optimize distribution and deliveryAntisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides.Target-specific arrest of mRNA translation by antisense 2'-O-alkyloligoribonucleotides.Inhibition of in vitro and ex vivo translation by a transplatin-modified oligo(2'-O-methylribonucleotide) directed against the HIV-1 gag-pol frameshift signal.Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin.Selective inhibition of cell-free translation by oligonucleotides targeted to a mRNA hairpin structure.Triplex-forming oligonucleotides trigger conformation changes of a target hairpin sequence.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.A novel dual lock method for down-regulation of genes, in which a target mRNA is captured at 2 independent positions by linked locked nucleic acid antisense oligonucleotides.An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers.RNase H is responsible for the non-specific inhibition of in vitro translation by 2'-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers.Monoclonal antibodies targeted to alpha-oligonucleotides. Characterisation and application in nucleic acid detection.Synthesis and base-pairing properties of the nuclease-resistant alpha-anomeric dodecaribonucleotide alpha-[r(UCUUAACCCACA)]Antisense therapy for lymphomas.Structure of the alpha-homo-DNA:RNA duplex and the function of twist and slide to catalogue nucleic acid duplexes.Chimeric alpha-beta oligonucleotides as antisense inhibitors of reverse transcription.Studies on antisense inhibition of translation in vitro. Anomalies and re-evaluation.Antisense oligonucleotides targeting translation inhibitory elements in 5' UTRs can selectively increase protein levels.Inhibition of neural crest cell attachment by integrin antisense oligonucleotides.Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides.Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs.Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides modulate CYP2B1 expression in vivo.
P2860
Q28345950-509014D5-C368-488D-A17A-6EB1F917B4C3Q33851819-5CEB68C6-4461-4F07-BF61-1B2A568516A0Q34079542-39BA13E6-4B1B-4B00-B5FE-77D86E50A4B7Q34204201-293006B0-E0D7-4DDC-ADC1-7C3E3FFF8E3EQ34588984-F1A936BB-A42B-4255-8FFE-199C4582D176Q35064569-D4E889E3-D33D-4A9C-B1F9-4886A1C8DDF8Q35668979-BD0EF290-FCF9-446F-991D-04C4DFC9F501Q35858691-C668BD79-23EC-404D-81EA-0A68EBAE4820Q35870795-DCD765A1-DFB7-4101-951B-8F5BB57F0CE7Q36798960-6FE422C8-6F5F-4B2D-A4B7-DD35A290706FQ38302506-2444774A-2E95-4E7B-B994-AB1EC139CFF9Q38317304-598356CC-588C-4FF6-8013-38B45E712FDBQ38327203-3BC2B614-B723-4EBD-8F9B-3E90CD8F7896Q38336876-C34E0009-E6ED-45D8-8C96-428720B617E4Q38353475-46459BFD-F785-4D4E-A7DE-D21BD62F6203Q38750210-7CB61FA5-D16C-4709-A27D-123C07FF4FAAQ40090404-B09E3209-F362-4161-862D-AAB3F3FA6DA6Q40393595-F140F22E-400C-478E-A32A-9232795430D1Q40395644-75D669CC-76CC-45C8-821B-0A61BB2F8763Q40411014-C7C71948-C7FA-4C6D-95D7-CEBFD5DF9B28Q40421057-20998950-DEAD-4A3C-8D7A-F20A9F207388Q41649099-0690D761-9E6D-4DB5-80E4-3803F196E7ECQ44024190-C697EC6F-6D7A-43E1-AF85-256944B27D2BQ44999745-66EA1A1C-6E43-4699-8694-F91BF8993D4BQ45287505-8B0DBC3A-61AF-41EE-98FA-B253594E531EQ46303317-CC821A83-E941-4707-953C-ED3CAFE71822Q46445259-5B95B76E-C855-4104-9D0E-8165F39C6207Q47134784-20BDAE42-8859-41E5-822E-184BAD7EA0A8Q47374105-62AD9A5A-292E-41DB-B33E-2341017B5306Q48827568-CFA61392-693A-469D-8B9C-BD02D05DE07E
P2860
Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism.
description
1991 nî lūn-bûn
@nan
1991 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մարտին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Inhibition of translation init ...... RNase-H independent mechanism.
@ast
Inhibition of translation init ...... RNase-H independent mechanism.
@en
Inhibition of translation init ...... RNase-H independent mechanism.
@nl
type
label
Inhibition of translation init ...... RNase-H independent mechanism.
@ast
Inhibition of translation init ...... RNase-H independent mechanism.
@en
Inhibition of translation init ...... RNase-H independent mechanism.
@nl
prefLabel
Inhibition of translation init ...... RNase-H independent mechanism.
@ast
Inhibition of translation init ...... RNase-H independent mechanism.
@en
Inhibition of translation init ...... RNase-H independent mechanism.
@nl
P2093
P2860
P356
P1476
Inhibition of translation init ...... RNase-H independent mechanism.
@en
P2093
P2860
P304
P356
10.1093/NAR/19.5.1113
P407
P577
1991-03-01T00:00:00Z